Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-012913
Filing Date
2024-05-10
Accepted
2024-05-10 18:06:59
Documents
1
Period of Report
2024-05-08

Document Format Files

Seq Description Document Type Size
1 form4-05102024_100550.html 4  
1 form4-05102024_100550.xml 4 5677
  Complete submission text file 0001415889-24-012913.txt   7128
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Issuer) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121
Business Address
GRAY SUSANNAH (Reporting) CIK: 0001833453 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36033 | Film No.: 24936350